Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017

Latest news articles

Added 8 days ago Drug news

RANGE study of Cyramza (ramucirumab) + docetaxel shows improvement in PFS in patients with urothelial carcinoma.- Eli Lilly.

At the European Society for Medical Oncology (ESMO) 2017 Congress Phase III RANGE data from Eli Lilly and Company were...

Added 1 month ago Drug news

NICE does not recommend Tecentriq(atezolizumab) from Roche to treat urothelial (bladder) cancer but suggests Roche make a proposal to Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) issued draft guidance recommending against Tecentriq (atezolizumab) from Roche for treating...

Added 1 month ago Drug news

NICE does not accept Keytruda (pembrolizumab) as a cost effective treatment for urothelial (bladder) cancer.- Merck Inc.

The National Institute for Health and Care Excellence (NICE) in preliminary guidance has decided that Keytruda ( pembrolizumab) from Merck...

Search all news articles for Cancer of bladder
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Breakthrough Cancer Pain Learning Zone

Invitation to watch the online broadcast of the BeCOn OWN event 'Shifting paradigms in BTcP management' on June 16 2017.

Visit Breakthrough Cancer Pain Learning Zone

Psoriasis

See information on psoriasis pathophysiology, signs and symptoms, comorbidities, treatment options, and more.

Visit Psoriasis

Guidelines

Guidelines on Upper Urinary Tract Urothelial Cell Carcinomas

The European Association of Urology (EAU) Non-muscle-invasive Bladder Cancer (NMIBC) Guidelines Panel has compiled these clinical guidelines to provide urologists...

Added 1 year ago

Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1 and CIS)

This overview represents the updated European Association of Urology (EAU) guidelines for Non-muscle-invasive Bladder Cancer (CIS, Ta, T1). The information...

Added 1 year ago

Guidelines on Muscle-invasive and Metastatic Bladder Cancer

The European Association of Urology (EAU) Guidelines Panel for Muscle-invasive and Metastatic Bladder Cancer (MIBC) has prepared these guidelines to...

Added 1 year ago

Search all guidelines for Cancer of bladder
 

Journal articles

A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now.

The treatment of bladder cancer has evolved over time to encompass not only the traditional modalities of chemotherapy and surgery, but has been particularly impacted by the use of immunotherapy.

Added 4 months ago

Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma.

Purpose: In this study, whether HOTAIR is a prognostic biomarker will be detected, and its regulative effects of chemosensitivity to...

Added 1 year ago

Search all journal articles for Cancer of bladder
 
Fiona Holland

Fiona worked in the fitness and wellness industry in the US for 13 years, supporting behaviour change in a variety of settings. Fiona’s research interests lie broadly within health and wellbeing. She is particularly interested in qualitative methodologies in the areas of body image ... Read more

What to say and do when someone has cancer

Ahead of World Cancer Day on Saturday (February 4), Fiona Holland, Psychology Lecturer, discusses what to say and what not to say to someone with cancer.

CME

Carcinoma of unknown primary origin: diagnosis and management: putting NICE guidelines into practice

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
90
Search all CME for Cancer of bladder